BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28045778)

  • 1. A 14-Year Audit and Analysis of Human Skin Allograft Discards.
    Spradbrow J; Etchells M; Cartotto R; Halliday A; Lin Y; Simor A; Visvalingam R; Callum J
    J Burn Care Res; 2017; 38(5):e786-e795. PubMed ID: 28045778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin donors and human skin allografts: evaluation of an 11-year practice and discard in a referral tissue bank.
    Gaucher S; Khaznadar Z; Gourevitch JC; Jarraya M
    Cell Tissue Bank; 2016 Mar; 17(1):11-9. PubMed ID: 26275343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadaveric allograft discards as a result of positive skin cultures.
    Obeng MK; McCauley RL; Barnett JR; Heggers JP; Sheridan K; Schutzler SS
    Burns; 2001 May; 27(3):267-71. PubMed ID: 11311520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors.
    Pianigiani E; Ierardi F; Cuciti C; Brignali S; Oggioni M; Fimiani M
    Burns; 2010 May; 36(3):347-51. PubMed ID: 19616385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to improve donor skin availability: Pragmatic procedures to minimize the discard rate of cryopreserved allografts in skin banking.
    Germain N; Hatzfeld AS; Pasquesoone L; Danze PM; Guerreschi P; Sendid B; Gaillot O; Marchetti P
    Burns; 2021 Mar; 47(2):387-396. PubMed ID: 32788056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial contamination rates during bone allograft retrieval.
    Journeaux SF; Johnson N; Bryce SL; Friedman SJ; Sommerville SM; Morgan DA
    J Arthroplasty; 1999 Sep; 14(6):677-81. PubMed ID: 10512439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving practice of the Helsinki Skin Bank.
    Lindford AJ; Frey I; Vuola J; Koljonen V
    Int Wound J; 2010 Aug; 7(4):277-81. PubMed ID: 20492012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial contamination of human skin allografts and antimicrobial resistance: a skin bank problem.
    Meneghetti KL; do Canto Canabarro M; Otton LM; Dos Santos Hain T; Geimba MP; Corção G
    BMC Microbiol; 2018 Sep; 18(1):121. PubMed ID: 30249183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sampling in the detection of microbial contamination on cadaveric allograft skin used as a biological wound dressing.
    May SR; Wainwright JF; DeClement FA
    Burns Incl Therm Inj; 1985 Oct; 12(1):36-48. PubMed ID: 3933768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial contamination of tissue allografts - experiences of the donor tissue bank of Victoria.
    Ireland L; Spelman D
    Cell Tissue Bank; 2005; 6(3):181-9. PubMed ID: 16151958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early use of allograft skin: are 3-day microbiologic cultures safe?
    Britton-Byrd BW; Lynch JP; Williamson S; McCauley RL
    J Trauma; 2008 Mar; 64(3):816-8. PubMed ID: 18332829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving efficiency of a regional stand alone bone bank.
    Warnock JM; Rowan CH; Davidson H; Millar C; McAlinden MG
    Cell Tissue Bank; 2016 Mar; 17(1):85-90. PubMed ID: 26138308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic skin donors from a tissue bank in Southern Brazil: clinical and epidemiological profiles and microbial colonization of skin.
    Pretto AS; Pretto L; Souza AFD; Chem EM; Ely PB; Bonamigo RR
    Int J Dermatol; 2019 Mar; 58(3):325-332. PubMed ID: 30246340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadaver donor discards secondary to serology.
    Barnett JR; McCauley RL; Schutzler S; Sheridan K; Heggers JP
    J Burn Care Rehabil; 2001; 22(2):124-7. PubMed ID: 11302599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in tissue bank practices regarding donor and tissue screening of structural allograft bone.
    Jurgensmeier D; Hart R
    Spine (Phila Pa 1976); 2010 Jul; 35(15):E702-7. PubMed ID: 20535046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can contamination of a patient's allograft be traced back to the allograft donor?
    Neely AN; Plessinger RT; Stamper B; Kagan RJ
    J Burn Care Res; 2008; 29(1):73-6. PubMed ID: 18182900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for donor cornea contamination: retrospective analysis of 4546 procured corneas in a single eye bank.
    Linke SJ; Fricke OH; Eddy MT; Bednarz J; Druchkiv V; Kaulfers PM; Wulff B; Püschel K; Richard G; Hellwinkel OJ
    Cornea; 2013 Feb; 32(2):141-8. PubMed ID: 22968360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioburden in transport solutions of human cardiovascular tissues: a comparative evaluation of direct inoculation and membrane filter technique.
    Kraft L; Ribeiro VST; Wollmann LC; Suss PH; Tuon FF
    Cell Tissue Bank; 2018 Sep; 19(3):447-454. PubMed ID: 29556882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bacterial contamination and predisposing factors during bone and tendon allograft procurement.
    Terzaghi C; Longo A; Legnani C; Bernasconi DP; Faré M
    Cell Tissue Bank; 2015 Mar; 16(1):151-7. PubMed ID: 24820865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of microbial contamination of corneal transplants: one-year report from a French regional eye bank.
    Khouani M; Debellemanière G; Malugani C; Gauthier AS; Pouthier F; Delbosc B; Saleh M
    Cornea; 2014 Sep; 33(9):899-904. PubMed ID: 25055144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.